Filter
7958
Filtered Results: 7958
Text search:
drugs
act
Featured
Recommendations
668
New Publications
2017
Language
Document type
No document type
4723
Studies & Reports
1195
Guidelines
1009
Manuals
361
Strategic & Response Plan
242
Fact sheets
174
Training Material
132
Situation Updates
37
Infographics
31
Brochures
25
Resource Platforms
18
Online Courses
7
Videos
2
Dashboards/Maps
1
App
1
Countries / Regions
India
467
Global
258
Kenya
230
South Africa
185
Ethiopia
161
Uganda
160
Nigeria
156
Western and Central Europe
154
Nepal
142
Sierra Leone
142
Tanzania
120
Liberia
120
Zambia
117
Latin America and the Carribbean
114
Malawi
113
Ghana
103
Bangladesh
98
Rwanda
97
Africa
97
Myanmar / Burma
95
Ukraine
87
Eastern Europe
75
Namibia
66
Philippines
65
Zimbabwe
58
Congo, Democratic Republic of
57
Russia
54
South–East Asia Region
51
Indonesia
51
Asia
50
Senegal
49
Syria
47
Cambodia
45
Lesotho
43
Burkina Faso
42
Mozambique
40
Germany
37
South Sudan
37
Botswana
35
Colombia
33
Brazil
31
Eswatini/ Swaziland
29
Haiti
26
Venezuela
26
Cameroon
23
West and Central Africa
23
Middle East and North Africa
22
East and Southern Africa
22
Guinea
21
Tajikistan
20
Benin
19
Peru
19
Eastern Europe and Central Asia
19
Paraguay
19
Argentina
19
Yemen
18
Chile
16
Sudan
16
Afghanistan
15
USA
15
Pakistan
15
Albania
14
Vietnam
13
Bolivia
12
Moldova
12
Georgia
12
Central African Republic
12
Thailand
11
Lebanon
11
Somalia
11
Madagascar
11
China
10
Laos
10
Mali
10
Armenia
9
Western Pacific Region
9
North America
9
North Macedonia
8
Mexico
8
Ecuador
8
El Salvador
7
Sri Lanka
7
Niger
6
Jordan
6
United Kingdom
6
Palestine
6
Iraq
6
Turkey
5
Angola
5
Libya
5
Bhutan
5
Iran
4
Fiji
4
Kyrgyzstan
4
Uzbekistan
4
Burundi
4
Guinea-Bissau
4
Saudi Arabia
4
Jamaica
4
Spain
4
Southern Africa
4
Côte d’Ivoire / Ivory Coast
4
Papua New Guinea
4
Egypt
4
Romania
4
Poland
4
Chad
4
Timor Leste/ East Timor
3
Serbia
3
Gambia
3
Kazakhstan
3
Morocco
3
Uruguay
3
Belarus
3
Djibouti
3
Greece
3
Canada
2
Singapore
2
Estonia
2
Mongolia
2
Qatar
2
Hungary
2
Lithuania
2
Gabon
2
Turkmenistan
2
Belgium
2
France
2
Mauritius
2
Tunisia
2
Portugal
2
Honduras
2
North Korea
1
Switzerland
1
Australia
1
Congo-Brazzaville
1
Bulgaria
1
Mauritania
1
Italy
1
Dominican Republic
1
Ireland
1
Japan
1
Denmark
1
Maldives
1
Norway
1
Azerbaijan
1
Latvia
1
Nicaragua
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
3065
Clinical Guidelines
670
Public Health
378
Women & Child Health
331
Key Resources
268
Capacity Building
132
Pharmacy & Technologies
83
Annual Report MEDBOX
2
Toolboxes
HIV
851
Mental Health
783
TB
670
COVID-19
446
AMR
342
NTDs
301
Pharmacy
241
Caregiver
183
NCDs
168
Rapid Response
150
Ebola & Marburg
143
Conflict
122
Refugee
121
Planetary Health
119
Disability
116
Global Health Education
82
Health Financing Toolbox
74
Natural Hazards
57
Zika
36
Cholera
31
Specific Hazards
29
Polio
28
Social Ethics
25
Malaria
15
South Sudan
2
These guidelines aim to guide all health care providers in Myanmar, accommodating the situation of different settings in the context of progressive decentralization of HIV services. Notable changes from the previous edition include:
• diagnosis of HIV
• update on the initiation of ART<...
• diagnosis of HIV
• update on the initiation of ART<...
The aim of the framework is to provide guidance to Member States and partners on region-specific priority actions towards the goals, targets and milestones of the GTS. The central pillar of the framework is the adoption of programme phasing and transitioning, aimed at facilitating a tailored approac...
Improving Infection Prevention and Control Practices at Health Facilities in Resource-Limited Settings
recommended
SIAPS Technical Report. This report summarizes key accomplishments and lessons learned in implementing SIAPS’ approach to improving IPC practices in four countries: South Africa, Namibia, Jordan, and Ethiopia. All activities address SIAPS’s overall objective to build or enhance national and faci...
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.
To understand the national situation, Ethiopia did a situation assessment, launched its first strategy in 2011, and took action to contain AMR, as detailed in the blue boxes found throughout this strategy. This updated version of the strategy was in response to the revised health and medicines polic...
Yaws, a neglected tropical disease (NTD) of the skin caused by the bacterium Treponema pallidum subspecies pertenue, is targeted in the latest WHO NTD Roadmap for eradication by 2030. In January, 2022, WHO published a manual that outlines the key activities that Ministries of Health in endemic count...
Updated recommendations on treatment of adolescents and children with chronic HCV infection
recommended
The new treatment recommendations that extend the 2018 treat all recommendation for adults with chronic HCV infection to include adolescents and children down to 3 years, and to align the existing recommended pangenotypic direct-acting antiviral (DAA) regimens (SOF/DCV, SOF/VEL and G/P) for adults, ...
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf...
The 2010-2011 National Annual Report on HIV program presents the progress in implementing the strategies and activities articulated in the National Strategic Plan on HIV and AIDS 2009-2012 commonly referred to as the HIV NSP. The report presents consolidated information regarding the outputs in the ...
LEAVING NO-ONE BEHIND | “A Journey to End NTDs – Elimination and Care” records what we have achieved over the last year and where we are now. It presents our plan of action for the coming years, bringing our ‘traditional’ NTD work together with ‘Disease Management Disability and Inclusio...
These are integrated National Guidelines 2013 for Prevention and Management of HIV, STIs & Other Blood Borne Infections in accordance with the last guidelines of the World Health Organization (WHO) published in June 2013 and adapted to the Rwandan national context. It thus responds to the need by th...
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been developed and forms part of the Five Year National Strateg...
In 2019, the Global Fund’s 6th Replenishment raised more than $USD14 billion to fight HIV, Tuberculosis and Malaria. Just two years later, the world has changed significantly. Put simply: COVID-19 devastated prevention and treatment programs. For the first time since the Global Fund’s founding, ...
These guidance notes on stress, grief and loss have been compiled by IMC’s Mental Health Advisor, Dr. Lynne Jones, for organizations working with Hurricane Katrina-affected populations. They represent lessons learned regarding mental health activities from IMC’s international experiences in disa...
Antimicrobials are widely used in food animal production, and use is rapidly increasing.
In an era of growing demand for animal products, there is an increasing trend towards the industrial production of food animals, especially in lower- and middle-income countries (LMICs). One hallmark of this me...
This new guidance aims to support programme implementers, coordinators and others in humanitarian settings in their actions to counter suicide and self-harm in humanitarian contexts and to save lives.
The approach is in line with two of the five objectives outlined in the Every Newborn Action Plan (ENAP): Strategic Objective 2 – Improve the quality of maternal and newborn care; and Strategic Objective 5 – Count every newborn through measurement, programme-tracking and accountability to genera...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regional and Country Offices has been invaluable: in ga...
Addendum: 2020 mid-year COVID-19 revision,summary of the reprioritisation & additional requirements in response to COVID-19
In June and July 2020, a mid-year revision of the 2020 Burundi Regional Refugee Response Plan (RRRP) was undertaken as an inter-agency consultative process to discuss and doc...
